Treatment of Mumps in Pediatric Patients
Treatment for mumps in children is entirely supportive, focusing on symptom management with rest, hydration, analgesics for pain and fever, and strict isolation to prevent transmission—there is no specific antiviral therapy available 1, 2.
Core Treatment Principles
The management of mumps is fundamentally symptomatic because no specific antiviral medication exists for this paramyxovirus infection 1. The treatment approach centers on:
Supportive Care Measures
- Pain and fever management: Use acetaminophen or ibuprofen for parotid pain, headache, and fever
- Hydration: Ensure adequate fluid intake, particularly important given the parotid involvement
- Rest: Encourage bed rest during the acute phase
- Soft diet: Recommend foods that don't require extensive chewing to minimize parotid discomfort
Critical Isolation Requirements
Isolation is paramount to prevent widespread outbreaks 1. Children with mumps should be isolated from others, particularly from school and daycare settings, as humans are the only known hosts and transmission occurs through respiratory droplets and saliva 1, 2.
Important Clinical Caveats
Airway Monitoring
While rare, laryngeal edema represents a potentially life-threatening complication 3. When significant neck swelling accompanies mumps, closely monitor for:
- Progressive dyspnea
- Stridor or voice changes
- Difficulty swallowing
If laryngeal edema develops, immediate interventions may include intravenous corticosteroids and potentially emergency airway management including intubation 3. This complication, though exceedingly rare, requires vigilant assessment when substantial cervical swelling is present.
Common Complications to Monitor
Beyond supportive care, watch for:
- Aseptic meningitis and encephalitis (common complications) 2
- Orchitis in post-pubertal males
- Pancreatitis (check for abdominal pain, elevated amylase) 3
- Hearing loss (can be permanent) 2
Diagnostic Confirmation
While diagnosis is primarily clinical based on characteristic parotid swelling, laboratory confirmation through PCR testing or IgM serology is available and recommended 1, 2. This is particularly important for:
- Public health reporting (mumps is reportable in most states) 1
- Outbreak investigation
- Cases with atypical presentations
Prevention Focus
The evidence emphasizes that vaccination remains the most effective intervention, with proper MMR administration providing approximately 80% protection 2. The guideline recommendations specify routine vaccination at 12-15 months for the first dose and 4-6 years for the second dose 4. However, once a child has active mumps infection, the focus shifts entirely to supportive management and transmission prevention.
Post-Exposure Considerations
For unvaccinated or incompletely vaccinated contacts, consider catch-up vaccination, though this will not prevent disease in those already exposed during the current incubation period 4.